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in the Evaluation of Low-risk Chest Pain
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Abstract. Objectives: To assess the impact of rest
sestamibi scanning on emergency physicians’ (EPs’)
diagnostic certainty and decision making (as assessed
by the hypothetical disposition of patients) for 69 con-
senting stable patients with suspected acute cardiac
ischemia and nondiagnostic electrocardiograms. The
resultant impact on costs was examined as a second-
ary outcome. Methods: Patients with suspected acute
cardiac ischemia were injected with 25 mCi of sesta-
mibi within two hours of active pain in one of three
emergency department study sites. The probability of
acute myocardial infarction (AMI) and unstable an-
gina (UA), and hypothetical disposition decisions
were recorded immediately before and after physi-
cians were notified of scan results. Changes in dis-
position were classified as optimal or suboptimal. For
the cost determinations, a cost-based decision support
program was used. Results: For the subgroup found
to be free of acute cardiac events (ACEs) (n = 62), the
EPs’ post-sestamibi scan probabilities for AMI de-
creased by 11% and UA by 18% (p < 0.001 for both
conditions). In seven patients with ACEs, the post-
scan probabilities of AMI and UA increased, but nei-
ther was statistically significant. Scan results led to
hypothetical disposition changes in 29 patients (42%),
of which 27 (93%) were optimal (nine patients were
reassigned to a lower level of care, two to a higher
level, and 16 additional patients to ‘‘discharge-home’’
status). The strategy of scanning all patients who
were low to moderate risk for acute cardiac ischemia
would result in an increase of direct costs of care of
$222 per patient evaluated, due to added cost of ses-
tamibi scanning. Conclusions: Sestamibi scanning
results appropriately affected the EPs’ estimates of
the probability of AMI and UA and improved dispo-
sition decisions. Scanning all low-risk patients would
likely be associated with increased costs at this med-
ical center. Key words: sestamibi imaging; chest pain;
cost evaluation; emergency department. ACADEMIC
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THERE are more than 5 million patient visitsin the United States to emergency depart-
ments (EDs) for complaints of chest pain. Of these,
approximately 2.5 million patients are admitted to
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the hospital for additional evaluation of suspected
acute cardiac ischemia.1 Acute ischemia is con-
firmed in only 10–30% of cases of those patients
admitted to the hospital with suspected disease.2,3
The economic cost of admitted, nondiseased pa-
tients is estimated to be $10 billion to $13 billion
per annum.4,5 Various technologies and diagnostic
strategies have been used to evaluate chest pain
patients to improve the quality, cost, and timeli-
ness of care.2,6–11 Technetium-99m (Tc-99m) sesta-
mibi has shown promise as a technology that can
reliably identify patients with acute ischemia in
the first few hours of care, distinguishing them
from those patients who can be safely discharged
home.12–15 Cost savings would hopefully result
from avoiding hospital admissions of nondiseased
patients in the latter group.
In our primary study of the value of resting ses-
tamibi for risk stratification of ED patients, we re-
ported its value for detecting acute cardiac events
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TABLE 1. Operational Definitions for Cost Analysis*
Direct Costs† Indirect Costs†














*Total cost reflect the sum of all direct and indirect costs.
†Items listed are representative (not all-inclusive) of types of
cost.
(ACEs) of death, acute myocardial infarction
(AMI), revascularization, and repeat hospitaliza-
tion for AMI or unstable angina (UA). Scanning
with sestamibi had a sensitivity of 71% and a spec-
ificity of 92% for ACEs occurring within a 12-
month follow-up period. The negative predictive
value was 97% and the positive predictive value
was 50%.16
The objectives of this follow-up study were to
assess the impact of rest Tc-99m sestamibi scan
results on the emergency physician’s (EP’s) diag-
nostic certainty for acute cardiac ischemia and its
effect on hypothetical disposition decisions. A sec-
ondary endpoint was the resulting impact on cost
of care.
METHODS
Study Design. This prospective study used a
pre- and posttest design to examine the effects of
sestamibi myocardial perfusion scanning on clini-
cal assessment and resource consumption. A study
coordinator was on site during the conduct of the
study and assessed physicians’ pre- and posttest
scanning clinical decisions regarding diagnosis and
disposition just before and after receiving the ses-
tamibi imaging test result. For the cost impact as-
sessment, only the hospital perspective was con-
sidered because of the importance this has for
hospital administration in justifying starting a
program of rest sestamibi scanning. The pre- and
posttest measures were the physicians’ estimates,
on a scale of 1 to 100, of the probabilities of AMI
and UA. The physician’s intended (hypothetical)
disposition for the patient was recorded. Regard-
less of intended disposition, all patients had stan-
dard surveillance of 12 hours of observation unit
care and, if needed, hospitalization, to confirm or
exclude cardiac ischemia.16 All patients were fol-
lowed for a 12-month period to determine whether
an ACE (defined as AMI or rehospitalization for
AMI, revascularization by percutaneous translu-
minal coronary angioplasty or coronary artery by-
pass grafting, or death—either cardiac or unex-
plained) occurred. The ED and hospital costs of
care (excluding professional fees) associated with
these disposition decisions were calculated using
the software Transition Systems Inc. (Eclipsys
Corporation, Delray Beach, FL). The institutional
review board approved the study protocol for the
university, and written informed consent was ob-
tained from all patients.
Study Setting and Population. This study took
place in three separate and distinct hospitals
within the Detroit Medical Center: hospital A (n =
46) is an urban emergency hospital with an annual
ED census of 75,000 and cares for adult acute
trauma and medical conditions for which 16% of
the ED patients are admitted to the hospital. Hos-
pital B (n = 13) is a community hospital with an
ED census of 27,000 of whom 23% are admitted to
the hospital, and hospital C (n = 13) is an urban
tertiary care hospital with an ED census of 24,000
(of whom 35% are admitted). Hospital A has a car-
diac observation unit (COU) in the ED run by
emergency medicine (EM) with routine consulta-
tion by an attending cardiologist. Hospital B has a
stepdown telemetry unit and a single intensive
care unit, which accommodates cardiac, medical,
and trauma cases as well as a nearby observation
unit. Hospital C has an adjacent observation area
that was considered a COU for purposes of this
study. It also has a separate stepdown telemetry
unit and a cardiac care unit (CCU) for the evalu-
ation and management of patients with suspected
ischemia. The Detroit Medical Center is affiliated
with Wayne State University School of Medicine
and all participating hospitals are residency train-
ing sites for EM residents.
Study Protocol and Measurements. Emergency
department patients at the three sites were pro-
spectively screened for enrollment from September
1996 to June 1997 during the hours of 7 AM to
3 PM Monday through Friday. The study protocol
has been published in detail in the report of the
diagnostic results.16 Briefly, a convenience sample
was chosen based on the availability of nuclear
medicine personnel. Adult patients (aged $18
years) with nontraumatic chest pain suggestive of
acute cardiac ischemia and having nondiagnostic
electrocardiograms (ECGs) and without cardiac
complications (defined as arrhythmias, heart fail-
ure, or shock) were included in the study. Excluded
were patients whose chest pain resolved more than
two hours prior to initial assessment, who were
pregnant, or who had a documented history of pre-
vious myocardial infarction, current cardiac com-
plications, or a diagnostic ECG ($1-mm ST-seg-
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Figure 1. Indicated are the possible patient dispositions on a scale of least to most acute. For patients with acute
cardiac events (ACEs), any disposition change going from a setting of more to less acuity would be considered
optimal. A disposition going from less to more acuity would be considered suboptimal. The reverse applies for
patients with an ACE. ED = emergency department.
ment elevation or depression or Q waves diagnostic
of AMI). Demographic and current medical data
were collected. The acute cardiac ischemia-time in-
sensitive predictive instrument17 was used to com-
pare the objective probabilities of acute cardiac is-
chemia among patients in the three different
hospitals.
According to protocol, patients were injected
with 25 mCI of sestamibi. Myocardial perfusion
image acquisition began 30 minutes to four hours
after injection. Patients were returned to either
the ED or the COU unless the test results dictated
immediate intervention.
Prior to receiving the sestamibi test result, the
EP was asked to provide a pre-sestamibi diagnostic
probability of the patient’s having AMI or UA
based on the information available at this juncture
using a questionnaire with a probability scale
ranging from 0 to 100. Physicians were also asked
to select one of five hypothetical dispositions (pre-
sestamibi disposition) for the patient based on
their own assessment: 1) CCU admission, 2) step-
down telemetry admission, 3) COU, 4) admission
to a medical floor, and 5) discharge from the ED.
Results of the sestamibi scans were interpreted
and reported to the EP by an expert reader (a nu-
clear cardiologist in the urban hospitals or a ra-
diologist credentialed to read nuclear scans in the
community hospital) as positive, negative, or
equivocal for a perfusion defect. For this analysis,
equivocal readings were classified with positive
readings. An expert nuclear cardiologist outside
the study institutions who was blinded to the clin-
ical data and the initial scan interpretation pro-
vided a second reading on a random sample of ses-
tamibi scans. Interrater reliability was high
(kappa value of 0.83, p < 0.001).
At this juncture, the physician was then asked
to reassess, based on the sestamibi scan’s interpre-
tation, the diagnostic probability of the patient’s
having an AMI or UA as well as one of the five
aforementioned post-sestamibi dispositions. As
previously described,16 all patients received stan-
dard surveillance for acute ischemia, including a
minimum of 12 hours of observation and testing
that consisted of ECGs (at times 0, 8, and 12
hours), cardiac enzymes (creatine phosphokinase-
MB; 0, 8, and 12 hours), standard cardiac rhythm
monitoring, and further individualized cardiac
testing as indicated. Although the EP recorded a
hypothetical disposition for each patient, the ac-
tual disposition decisions beyond the 12-hour sur-
veillance period were decided jointly by the EP and
the patient’s primary care provider or consulting
cardiologist.
Cost Impact. The actual hospital costs for the
care of each patient were determined from the
cost-based decision support program used by each
institution, Transition Systems Inc., as used in
other cost–effectiveness studies.18 The analysis of
costs was done using output for both variable di-
rect costs and total costs (Table 1). The mean costs
for each treatment disposition site and stay (CCU,
telemetry, etc.) were determined for each institu-
tion. These actual mean costs were then weighted
by patient enrollment and averaged across hospi-
tals to provide a mean for each disposition site for
all hospitals (average systemwide cost). These ac-
tual mean costs were then used to determine the
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Figure 2. Indicated are the changes in probability of unstable angina (UA) before and after the emergency phy-
sician received the sestamibi scan results. In acute cardiac event positive (ACE1) patients, the pre-scan probability
of UA was already high, and the scan results increased it only an average of 4.2% (p = 0.9). In contrast, in ACE2
patients, although the pre-scan probability of UA was 38.9%, the scan results led, on average, to a reduction of
the probability by 18% (p < 0.001).
associated costs of each hypothetical pre- and post-
sestamibi disposition decisions. Since the study
protocol did not permit patients to be immediately
discharged, the average costs for patients dis-
charged from the ED were determined by concur-
rent retrospective review of such cases for each in-
stitution. Similarly, since only one patient in the
study was admitted to unmonitored floor beds, the
costs for hypothetical floor dispositions were deter-
mined in the same fashion.
To assess the impact of sestamibi test results
on costs of care, these (hypothetical) disposition
changes were linked to the actual costs incurred
by study patients by analyzing accounting data
generated by the Transition Systems Inc. system.
Examples of components of various types of costs
are supplied in Table 1.
Data Analysis. The primary outcome was the
change in pre- and posttest probabilities of AMI
and UA and optimal or suboptimal changes in pa-
tient disposition status. Post-sestamibi disposi-
tions were subsequently classified as optimal or
suboptimal disposition changes, after determina-
tion of the presence or absence of ACE status (Fig-
ure 1). For patients with no ACEs, optimal dispo-
sition changes were defined as going from a more-
to a less-intensive nursing setting. Suboptimal dis-
position changes for patients without ACEs in-
cluded changes that went from less-intense ser-
vices to more-intense services. Corresponding
definitions applied to patients with ACEs: optimal
disposition changes included changes that went
from less-acute dispositions to more-acute dispo-
sitions, whereas suboptimal changes were those
that went from more-acute to less-acute disposi-
tions. Acute myocardial infarction and UA were de-
fined by criteria applied without reference to the
sestamibi scan outcome. The intensity of nursing
and patient monitoring was ranked from highest
to lowest. Although this ranking is ordered, the in-
terval differences between levels are not necessar-
ily equal. The rank order is as follows: CCU, step-
down telemetry unit, COU, medical ward, and
discharge home.
Descriptive statistics were calculated for all
continuous variables, including means 6 standard
deviations (SDs). Frequencies were calculated for
ACE status. Analysis of variance was used to de-
termine whether the mean acute cardiac ischemia
scores differed between the three hospitals.19 Pre-
sestamibi and post-sestamibi UA and AMI proba-
bilities were obtained, and the signed-rank test
was used to determine whether differences existed
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Figure 3. Indicated are the changes in probability of acute myocardial infarction (AMI) before and after the emer-
gency physician received the sestamibi scan results. In acute cardiac event positive (ACE1) patients, the pre-scan
probability of AMI was relatively low, and the scan results increased it substantially by approximately 26%. This
result, however, was not statistically significant (p = 0.09), due to small sample size. In contrast, in ACE2 patients,
although the pre-scan probability of AMI was 17.2%, the scan results led, on average, to a reduction of the prob-
ability by 11% (p < 0.001).
between pre- and post-sestamibi probabilities of
UA and AMI. Additionally, the effect of sestamibi
scanning on diagnostic probability between ACE-
positive and ACE-negative patients was assessed
using multivariate analysis of variance (MAN-
OVA).19 The dependent variables included the dif-
ference in probability of UA and AMI (post-sesta-
mibi probability minus pre-sestamibi probability).
A secondary endpoint was the difference in
costs of utilizing a sestamibi scan versus no ses-
tamibi scan strategy. Direct and total costs were
calculated for pre-sestamibi and post-sestamibi
dispositions. For each cost variable, the means
were calculated after weighting the number of pa-
tients at each hospital by each hospital’s cost. The
signed-rank test was then used to determine
whether these costs were significantly different.
For all statistical analyses, p-values were consid-
ered significant. Analyses were performed using
the SAS System, Version 8.0 (SAS Institute Inc.,
Cary, NC).
RESULTS
The mean age of the study population (n = 69) was
56 years and 43% were male; 74% were African
American and 26% were white. Of these patients,
10% (n = 7) had ACEs and 90% (n = 62) were ACE-
negative during the 12-month follow-up period. Of
the seven patients with ACE, three were deter-
mined to have had a myocardial infarction and
four required revascularization; one subsequently
experienced cardiac arrest and died. The patients’
mean (6SD) acute cardiac ischemia scores were
not statistically significantly different between the
three study sites: hospital A = 29% (617), hospital
B = 27% (613), and hospital C = 27% (66) (p =
0.96). As previously reported, there was no clinical
difference between the groups with and without
ACEs.16
There were significant overall differences in the
pre- and post-sestamibi probabilities for UA and
AMI. Among all patients (n = 69), the pre-sesta-
mibi UA probability was 39.8% (623.0), and the
post-sestamibi UA probability was 23.8% (625.6).
The absolute mean difference between the post-
sestamibi scan probability and the pre-sestamibi
scan probability of UA was 15.9% (p < 0.001).
Among all patients, the pre-sestamibi AMI proba-
bility was 17.8% (616.3), while the post-sestamibi
AMI probability was 10.7% (621.9), resulting in an
absolute mean difference of 7.1% (p < 0.01).
The statistical modeling using MANOVA
showed an overall statistically significant change
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Figure 4. The cost impact of the cohort of patients tested with sestamibi.
in pre- and posttest probabilities in the study
group (p-value of Wilks’ lambda <0.001). The re-
sults of the MANOVA indicated that there was a
difference between the UA and AMI probabilities
(pre- vs post-sestamibi scan) among patients with
ACE and without ACE. Figure 2 illustrates the
change in physician UA probability before and af-
ter receiving the sestamibi scan results. Among
ACE patients (n = 7), the physicians’ pre- and post-
sestamibi probabilities of UA were 47.1% (624.3)
and 51.3% (634.9), respectively, for an absolute
mean difference of 4.2%, but this difference was
not statistically significant, p = 0.90. Among pa-
tients without ACE (n = 62), the physicians’ pre-
and post-sestamibi probabilities of UA were 38.9%
(622.9) and 20.7% (622.6), respectively, for an ab-
solute mean difference of 18.2%, p < 0.001.
Figure 3 illustrates the change in physicians’
assessments of probability of AMI before and after
receiving the sestamibi scan results. Among ACE-
positive patients, the physicians’ pre- and post-ses-
tamibi probabilities of AMI were 22.9% (622.2)
and 48.7% (637.2), respectively, for an absolute
mean difference of 25.8%; however, this difference
was not statistically significant (p = 0.09), possibly
due to the small sample size (n = 7). Among ACE-
negative patients, the physicians’ pre- and postses-
tamibi probabilities of AMI were 17.2% (615.7)
and 6.4% (614.7), respectively, for an absolute
mean difference of 10.8%, p < 0.001. This study
had a power of 0.75 to detect a 10% change and a
power of 0.99 to detect a 20% change in the prob-
ability of AMI.
Changes in hypothetical dispositions were con-
cordant with changes in diagnostic probability. Fol-
lowing the results of the sestamibi scan, 42% (n =
29) of all patients had a change in their planned
dispositions. There were 27 optimal changes and
two non-optimal changes. Among those with opti-
mal changes, two patients went from a lower level
to a higher level of care (these two patients sub-
sequently had ACEs) and 25 patients were reas-
signed to a lower level of care. Among the 25 reas-
signed to a less-intense setting, nine went to a
lower level of care and 16 were assigned to ED dis-
charge; none of these patients experienced an ACE.
Among those who were subject to non-optimal
changes, two patients had negative sestamibi per-
fusion scans, but the scans showed that both had
left ventricular dysfunction; neither patient had an
ACE. Both these patients were upgraded following
the sestamibi scan. It is important to note that
there were no suboptimal ‘‘upgraded’’ dispositions
due to false-positive sestamibi scans. Additionally,
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TABLE 2. Variable Direct Costs (in Dollars) by Unit Ranging from the Least Acute Disposition (Emergency Department














Hospital A* 101 337 199 824 1449
Hospital B† 135 413 439 782 693
Hospital C‡ 150 338 878 866 1934
*Urban emergency department, annual census of 75,000.
†Community emergency department, annual census of 27,000.
‡Urban emergency department, annual census of 24,000.
TABLE 3. Total Costs by Unit (Dollars) Ranging from the Least Acute Disposition (Emergency Department Discharge) to the












Hospital A* 334 950 532 2,559 4,218
Hospital B† 386 1,080 1,147 2,153 2,110
Hospital C‡ 433 1,182 2,550 2,966 5,056
*Urban emergency department, annual census of 75,000.
†Community emergency department, annual census of 27,000.
‡Urban emergency department, annual census of 24,000.
there were no discharges recommended for pa-
tients who subsequently developed an ACE.
Figure 4 illustrates the financial impact of ses-
tamibi scanning of all 69 patients—including and
excluding the cost of the sestamibi scanning itself.
The following results are reported in variable di-
rect or total costs per patient (Table 1). Based on
the variable direct and total costs by hospital pre-
sented in Tables 2 and 3, the variable direct and
total costs for patient dispositions prior to the ses-
tamibi scan were $536 per patient and $1,560 per
patient, respectively (Fig. 4). Using the same cost
data in Tables 2 and 3 and excluding the cost of
the scan, the variable direct and total costs follow-
ing the sestamibi scan were reduced to $422 (p <
0.01) and $1,252 (p < 0.01), respectively, due to 25
patients’ being assigned to lower, less-costly levels
of care. The post-scanning variable direct cost, af-
ter adding the cost of sestamibi scanning ($336 per
patient), was $758 per patient. The post-scanning
total cost, after adding the cost of sestamibi scan-
ning ($616 per patient), was $1,868. The savings
in variable direct costs per patient associated with
the change in dispositions was $114, which was
less than the cost of $336 for sestamibi scanning.
After including the direct cost of the scan ($336
per patient), the direct cost increased by $222 per
patient. Similarly, the savings in total per-patient
cost associated with the change in dispositions was
$309 per patient. After including the total cost for
the sestamibi scan ($616 per patient), the total cost
increased by $307 per patient to $1868. Thus, after
including the cost of the sestamibi scan itself, the
use of these scans would actually increase the
overall total costs for the medical center as a whole
according to the model used in this study.
DISCUSSION
Diagnostic Probability and Effect on Disposi-
tion. To the best of our knowledge, this study is
the first to examine the effect of sestamibi scan-
ning on decision making by EPs. The study eval-
uated both the effect on the diagnostic probabili-
ties of AMI and UA and the changes in disposition
that such quantitative changes in diagnostic prob-
abilities might prompt. We found that sestamibi
scanning was particularly helpful in augmenting
diagnostic confidence in the direction of decreased
probability of AMI or UA in non-ACE patients. The
EP’s diagnostic certainty based on sestamibi test
results also changed in the appropriate direction
in the subgroup with ACE, but this trend did not
reach statistical significance, in part because of the
smaller size of this subgroup. The use of the ses-
tamibi scan permitted the EPs to send 42% of non-
diseased patients to a lower level of care, a change
that is optimal from the point of resource use
matching disease status.16
To achieve cost savings, excellent specificity is
necessary but not sufficient. A high sensitivity is
also needed so that physicians will have strong
confidence that negative scans are likely to be true
negatives. Although the sensitivity of the scan for
both early and late (12-month) cardiac events was
71%, its negative predictive value was 97%. Hilton
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and colleagues have also shown that the sestamibi
scanning has good to excellent specificity (95%)
and moderate sensitivity (83%).13
In a similar fashion, Weissman and colleagues20
reported that rest sestamibi scans improved the di-
agnostic certainty of cardiologists caring for chest
pain patients. In their study, a scale of 1 to 5 was
used to rate diagnostic certainty for cardiac versus
noncardiac chest pain (1 = no confidence, 5 = very
confident). The attending cardiologist’s diagnostic
certainty in the current working diagnosis of car-
diac versus noncardiac chest pain increased from
2.92 to 4.52.20
Our results and those here discussed have im-
portant clinical and financial implications. For pa-
tients in whom AMI is suspected, sestamibi scan-
ning can raise the probability of this diagnosis and
identify a group that may benefit from more ag-
gressive diagnostic and therapeutic interventions.
Patients who are thought to have a low probability
for ACE, and who have a negative scan, are can-
didates for discharge home immediately or after an
ED COU stay. Stress testing may be considered
prior to discharge, or can be arranged on a timely
basis in the outpatient setting based on clinical
risk stratification criteria. An advantage of our
study over previous reports is that it included pa-
tients from three different hospital settings, which
increases its generalizability.
Financial Impact of Scanning. Unlike other
studies,20–22 the methodology used here for study-
ing the financial impact of sestamibi scanning
showed that a scan strategy resulted in a higher
overall cost in our medical center. Such outcomes
are clearly dependent on the alternative costs in-
volved in not scanning versus scanning patients at
low risk of disease. At EDs where the alternative
to scanning is a relatively low-cost ED-based COU,
the scan strategy is likely to prove more expensive.
In settings where scanning leads to avoided hos-
pital admissions, larger cost savings can accrue
and the scan strategy, despite the cost of additional
nuclear testing, may lead to overall cost savings.
The lack of cost savings found in our study was
largely due to the small savings accrued by avoid-
ing the low- (rather than high-) cost evaluations in
the COU at hospital A, where most patients were
enrolled.
Weissman et al. reported that myocardial per-
fusion imaging with sestamibi for admitted chest
pain patients is potentially cost-effective.20 The
methodology in this study was to calculate the av-
erage length of stay and cost per admission based
on six-month retrospective analysis of 381 consec-
utive admissions for unexplained chest pain. Es-
timates of cost savings were based on numbers of
admissions avoided, assigning a relatively high
cost savings for all such patients. Radensky and
colleagues reported cost savings using both Medi-
care-based cost data from a retrospective cohort
and cost accounting data comparing the costs of
traditional in-hospital chest pain evaluation on
low-risk patients versus an ED evaluation strategy
using Tc-99m sestamibi that allowed low-risk pa-
tients with negative scans to be discharged home
for further outpatient evaluation.21 These authors
reported cost savings due primarily to avoiding un-
necessary admissions. Neither of these analyses
considered the lower-cost medically-equivalent al-
ternatives for the evaluation of chest pain that ex-
ist today in ED-based COUs.
Heller et al., using Tc-99m tetrofosmin rather
than Tc-99m sestamibi, in a multicenter study, em-
ployed a net cost analysis to compare the potential
cost savings from reduced hospital admissions
with the increased diagnostic cost of single-photon-
emission computed tomography (SPECT) imag-
ing.22 Actual hospital charges for all patients, and
the cost of performing SPECT imaging, were ob-
tained and then analyzed according to two differ-
ent strategies. One strategy called for all patients
with normal scans to be discharged, and the other
allowed 20% of patients with normal scans to be
admitted based on clinical information. Both strat-
egies showed cost savings on the basis of hospital
days avoided, but this study was done on admitted
patients and an ED-based observation unit was not
used.
LIMITATIONS AND FUTURE QUESTIONS
One limitation of this study is that the hypotheti-
cal pre- and post-sestamibi disposition decisions
used may differ from actual decisions that these
physicians would have made, and this potential
disparity could change study outcomes. The EP’s
actual disposition decision may be influenced by
the patient’s primary care provider, liability con-
cerns, or other factors. A randomized controlled
study using actual dispositions would obviate this
problem.
Improved quality of care was not measured in
this study. We believe that the quality of care was
enhanced by the use of sestamibi,16 but such ben-
efits were not quantified or captured by our anal-
ysis. Anecdotal reports from clinicians showed that
the scans often expedited the diagnosis of AMI or
UA, with some patients going from the scan suite
to the cardiac catheterization lab for an interven-
tion. Negative scans can also be helpful. For ex-
ample, in the case of a patient with an aortic dis-
section; a negative rest sestamibi scan expedited
the consideration of the correct alternative diag-
nosis. If sestamibi scanning improves quality of
care, then a cost–effectiveness study might dem-
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onstrate its economic value. In addition, we did not
measure patient satisfaction, but if evaluation
time were reduced due to scanning, satisfaction
might be favorably affected.
CONCLUSIONS
Sestamibi scanning in low-risk chest pain patients
improves the certainty of diagnostic assessments
and appropriateness of disposition decisions. Most
of the changes in disposition would lead to care in
less costly areas of the hospital (or hospital dis-
charge from the ED). Scanning all low-risk pa-
tients would likely be associated with increased
costs at our medical center. The degree to which
lower costs of care offset the increased cost of ses-
tamibi scanning depends on the local hospital en-
vironment and the associated costs of evaluating
patients with suspected acute cardiac ischemia.
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